Skip to content
Screener
Satellos Bioscience logo

Satellos Bioscience

MSLE

Satellos Bioscience is a medical - pharmaceuticals company in the healthcare sector trading on XNAS, led by CEO Francis Gleeson, with a market cap of $158.9M.

Market cap
$158.91M-36.1%

We’re still putting together Satellos Bioscience’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.

Ask us to move Satellos Bioscience up the queue, and we’ll analyze its filings next.

Earnings

Q3 2026 report

November 12, 2026

Next report

Date not yet announced

Profile

CountryCanada
Listed2021
Employees17.0
CEOFrancis Gleeson
FilingsSEC EDGAR